{"organizations": [], "uuid": "e2301737102e0d40952ee6c57fb737612febc0db", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-montreux-equity-partners-reports-9/brief-montreux-equity-partners-reports-9-26-pct-passive-stake-in-sonoma-pharmaceuticals-idUSFWN1QR0TS", "country": "US", "domain_rank": 408, "title": "BRIEF-Montreux Equity Partners Reports 9.26 Pct Passive Stake In Sonoma Pharmaceuticals", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T22:50:00.000+02:00", "replies_count": 0, "uuid": "e2301737102e0d40952ee6c57fb737612febc0db"}, "author": "", "url": "https://www.reuters.com/article/brief-montreux-equity-partners-reports-9/brief-montreux-equity-partners-reports-9-26-pct-passive-stake-in-sonoma-pharmaceuticals-idUSFWN1QR0TS", "ord_in_thread": 0, "title": "BRIEF-Montreux Equity Partners Reports 9.26 Pct Passive Stake In Sonoma Pharmaceuticals", "locations": [], "entities": {"persons": [], "locations": [{"name": "sonoma", "sentiment": "none"}], "organizations": [{"name": "brief-montreux equity partners reports", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "sonoma pharmaceuticals reuters", "sentiment": "none"}, {"name": "pharmaceuticals", "sentiment": "none"}, {"name": "montreux equity partners v lp", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9 (Reuters) - Montreux Equity Partners V LP:\n* MONTREUX EQUITY PARTNERS REPORTS 9.26 PERCENT PASSIVE STAKE IN SONOMA PHARMACEUTICALS AS OF MARCH 2 - SEC FILING Source text: ( bit.ly/2FvWSFR ) Further company coverage:\n ", "external_links": [], "published": "2018-03-09T22:50:00.000+02:00", "crawled": "2018-03-09T23:09:04.009+02:00", "highlightTitle": ""}